Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Gene and Gene-modified Cell Therapies Medical Education
Release Date:
Partner: American Society of Gene + Cell Therapy
Review Process: Expert Review Panel
Education Rare Disease All
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Improving Care for Patients with Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice Providers
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Improving Health Equity in IBD through Disparities Research
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Opportunities
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
2023 Inflammatory Bowel Disease (IBD) Fellowship – India
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology India
Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-Pacific
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD Patients
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
Diversity in Postmarketing Drug Safety Surveillance
Release Date:
Review Process: Pfizer Internal
Research Patient Safety USA
Ulcerative Colitis (UC) Research
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology Albania, Andorra, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Israel, Italy, Korea, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
Addressing Systemic Drivers of Racial Health Inequities
Release Date:
Review Process: Pfizer Internal
Quality Improvement Health Equity USA